Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase during normothermic perfusion of DCD donor livers before transplantation
ISRCTN15211703Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label, single-arm trial of tissue-plasminogen activator and fresh-frozen plasma in hepatic disease, sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Post reperfusion intra-operative blood loss. Started Aug 2021; status: completed.
02
Drugs
tissue-plasminogen activatorfresh-frozen plasma
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ISRCTN15211703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15211703.